CONMED Gross Margin 2010-2022 | CNMD

Current and historical gross margin for CONMED (CNMD) over the last 10 years. The current gross profit margin for CONMED as of June 30, 2022 is %.
CONMED Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-06-30 $1.04B $0.59B 56.24%
2022-03-31 $1.02B $0.58B 56.37%
2021-12-31 $1.01B $0.57B 56.08%
2021-09-30 $0.99B $0.55B 55.25%
2021-06-30 $0.98B $0.54B 55.06%
2021-03-31 $0.88B $0.47B 53.29%
2020-12-31 $0.86B $0.46B 53.42%
2020-09-30 $0.88B $0.47B 53.37%
2020-06-30 $0.87B $0.46B 53.16%
2020-03-31 $0.95B $0.52B 54.89%
2019-12-31 $0.96B $0.52B 54.87%
2019-09-30 $0.93B $0.52B 55.26%
2019-06-30 $0.90B $0.50B 55.11%
2019-03-31 $0.88B $0.48B 54.97%
2018-12-31 $0.86B $0.47B 54.71%
2018-09-30 $0.84B $0.46B 54.88%
2018-06-30 $0.83B $0.45B 54.71%
2018-03-31 $0.81B $0.44B 54.43%
2017-12-31 $0.80B $0.43B 54.20%
2017-09-30 $0.78B $0.42B 53.34%
2017-06-30 $0.77B $0.41B 53.43%
2017-03-31 $0.77B $0.41B 53.32%
2016-12-31 $0.76B $0.41B 53.47%
2016-09-30 $0.75B $0.40B 53.73%
2016-06-30 $0.73B $0.40B 53.95%
2016-03-31 $0.72B $0.39B 53.60%
2015-12-31 $0.72B $0.38B 52.99%
2015-09-30 $0.72B $0.38B 52.97%
2015-06-30 $0.73B $0.39B 52.81%
2015-03-31 $0.74B $0.39B 53.40%
2014-12-31 $0.74B $0.40B 54.59%
2014-09-30 $0.75B $0.41B 54.95%
2014-06-30 $0.75B $0.41B 54.52%
2014-03-31 $0.76B $0.41B 54.43%
2013-12-31 $0.76B $0.41B 54.07%
2013-09-30 $0.76B $0.41B 53.68%
2013-06-30 $0.76B $0.41B 53.87%
2013-03-31 $0.76B $0.41B 53.68%
2012-12-31 $0.77B $0.41B 52.93%
2012-09-30 $0.75B $0.40B 52.53%
2012-06-30 $0.74B $0.39B 52.22%
2012-03-31 $0.74B $0.38B 51.49%
2011-12-31 $0.73B $0.37B 51.59%
2011-09-30 $0.72B $0.37B 51.04%
2011-06-30 $0.72B $0.37B 50.83%
2011-03-31 $0.72B $0.37B 51.39%
2010-12-31 $0.71B $0.37B 51.33%
2010-09-30 $0.72B $0.37B 51.53%
2010-06-30 $0.72B $0.37B 51.18%
2010-03-31 $0.71B $0.35B 49.93%
2009-12-31 $0.70B $0.34B 48.49%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.967B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
McKesson (MCK) United States $50.991B 14.81
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
Invacare (IVC) United States $0.033B 0.00